Loading...
XASX
AHX
Market cap64mUSD
Aug 08, Last price  
0.54AUD
1D
-0.92%
1Q
31.71%
Jan 2017
-56.80%
IPO
-56.80%
Name

Apiam Animal Health Ltd

Chart & Performance

D1W1MN
No data to show
P/E
20.14
P/S
0.49
EPS
0.03
Div Yield, %
3.70%
Shrs. gr., 5y
11.23%
Rev. gr., 5y
12.87%
Revenues
205m
+6.73%
054,097,00097,991,000106,597,000111,720,000118,335,000126,181,000157,057,000191,757,000204,656,000
Net income
5m
+116.56%
-748,00050,0005,027,0003,278,0003,165,0004,171,0005,082,0004,639,0002,277,0004,931,000
CFO
19m
+8.15%
-652,000-1,237,0001,670,0009,217,0004,884,0007,507,00013,689,00015,078,00017,455,00018,878,000
Dividend
Aug 28, 20240.01 AUD/sh
Earnings
Aug 21, 2025

Profile

Apiam Animal Health Limited, a vertically integrated animal health company, provides veterinary products and services to production and companion animals in Australia. The company operates through three segments: Dairy and Mixed, Feedlots, and Pigs. It engages in the provision of veterinary wholesale, diagnostics laboratories, custom vaccines, logistics, and other ancillary services. The company offers companion animal, dairy, swine and poultry, beef feedlot, equine, sheep, and genetic services. It also provides telemedicine, remote video headgear, health management apps for production animals systems, benchmarking databases, and herd management software. The company offers general animal health products through eCommerce. It provides its services through animal veterinary clinics. The company was founded in 1998 and is based in Bendigo, Australia.
URL
https://www.apiam.com.au/
IPO date
Dec 15, 2015
Employees
950
Domiciled in
AU
Incorporated in
AU

Valuation

Title
AUD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑062016‑06
Income
Revenues
204,656
6.73%
191,757
22.09%
Cost of revenue
158,557
185,598
Unusual Expense (Income)
NOPBT
46,099
6,159
NOPBT Margin
22.53%
3.21%
Operating Taxes
2,154
995
Tax Rate
4.67%
16.16%
NOPAT
43,945
5,164
Net income
4,931
116.56%
2,277
-50.92%
Dividends
(1,322)
(673)
Dividend yield
2.11%
0.74%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
5,913
7,918
Long-term debt
133,380
114,152
Deferred revenue
1
24,043
Other long-term liabilities
1,116
1,049
Net debt
137,263
118,624
Cash flow
Cash from operating activities
18,878
17,455
CAPEX
(4,778)
(8,205)
Cash from investing activities
(10,907)
(40,620)
Cash from financing activities
(9,386)
23,492
FCF
39,576
(3,394)
Balance
Cash
1,757
3,172
Long term investments
273
274
Excess cash
Stockholders' equity
122,029
117,896
Invested Capital
224,924
216,972
ROIC
19.89%
2.66%
ROCE
20.22%
2.79%
EV
Common stock shares outstanding
181,989
177,762
Price
0.35
-32.35%
0.51
-25.55%
Market cap
62,786
-30.74%
90,659
-4.19%
EV
200,054
209,311
EBITDA
46,099
16,386
EV/EBITDA
4.34
12.77
Interest
5,523
3,774
Interest/NOPBT
11.98%
61.28%